Order number: 33T5.1
Part number: AC100008740
Recommended for applications requiring controlled solvent behavior, the Hplc Column Nucleodur ® C 18 Gravity offers a high density C 18 phase based on high purity NUCLEODUR ® silica gel. Its endcapping feature suppresses unwanted polar interactions, making it ideal for separating basic and other ionizable analytes. With enhanced pH stability, LC/MS suitability, and superior base deactivation, this UHPLC column is an excellent choice for method development and valuable for RP applications. It's particularly useful in separating compounds with ionizable functional groups like basic pharmaceuticals and pesticides.
| Name | Value | |
|---|---|---|
| Phase | : | C 18 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | UHPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L1 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 0.2 ml |
| Particle size | : | 1.8 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 18 HD Xterra ® RP 18 / MS C 18 Luna ® C 18 (2) Gemini ® Synergi™ Max RP Zorbax ® Extend C 18 Inertsil ® ODS III Purospher ® Star RP-18 Hypersil™ BDS |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density octadecyl (C 18 , ODS) modification |
| Pressure stability | : | 900 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 30 x 3 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
© 2026 Copyright. All Rights Reserved.
© 2026 Copyright. All Rights Reserved.